We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ARTL market cap is 4.21M. The company's latest EPS is USD -2.9129 and P/E is -0.45.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.48M | -2.29M | -1.78M | -2.61M | -3.24M |
| Net Income | -3.34M | -2.17M | -1.6M | -2.45M | -3.07M |
| Year End December 30 2023 | 2020 | 2021 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.69M | -7.44M | -4.04M | -10.29M | -9.93M |
| Net Income | -4.66M | -7.44M | -4.04M | -10.08M | -9.29M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 20.42M | 18.48M | 16.88M | 15.5M | 13.04M |
| Total Liabilities | 1.02M | 840k | 609k | 921k | 1.29M |
| Total Equity | 19.4M | 17.64M | 16.27M | 14.58M | 11.75M |
| Year End December 30 2023 | 2020 | 2021 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 4.38M | 12.64M | 28.25M | 20.42M | 13.04M |
| Total Liabilities | 502k | 593k | 1.08M | 1.02M | 1.29M |
| Total Equity | 3.88M | 12.04M | 27.17M | 19.4M | 11.75M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -8.01M | -2.19M | -3.81M | -5.61M | -8.21M |
| Investing | 2.96M | 2.2M | 2.6M | 766k | 3.51M |
| Financing | N/A | N/A | N/A | 535k | 567k |
| Year End December 30 2023 | 2020 | 2021 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.35M | -6.14M | -2.67M | -8.01M | -8.21M |
| Investing | N/A | -3.44M | -10.03M | 2.96M | 3.51M |
| Financing | 1.98M | 14.11M | 18.26M | N/A | 567k |
| Market Cap | 4.21M |
| Price to Earnings Ratio | -0.45 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.5 |
| Price to Book Ratio | 0.36 |
| Dividend Yield | - |
| Shares Outstanding | 3.19M |
| Average Volume (1 week) | 16.98k |
| Average Volume (1 Month) | 12.24k |
| 52 Week Change | -21.42% |
| 52 Week High | 2.98 |
| 52 Week Low | 1.15 |
| Spread (Intraday) | 0.2 (13.33%) |
| Company Name | Artelo Biosciences Inc |
| Address |
564 wedge lane fernley, nevada 89408 |
| Website | https://www.artelobio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
